Instrument Inactif

Communiqués OssDsign AB (publ) OTC Markets

Actions

OSSDF

SE0012570448

Equipement, fournitures et distribution médicale

Communiqués

31/08	OssDsign: Highlights from DNB Carnegie Micro Cap Day	AQ
28/08	Interim Report - January-June 2026	AQ
19/08	OssDsign: Growth recovery remains elusive – Q2 review	AQ
18/08	OssDsign: Q2 initial – Weak quarter as expected	AQ
18/08	OssDsign AB (publ) publishes Q2 2026 interim report	AQ
11/08	OssDsign: We expect a sluggish Q2, eyeing H2 recovery – Q2 preview	AQ
25/06	OssDsign appoints Adam McCollister as new Vice President of Sales	AQ
10/06	Annual General Meeting held in OssDsign AB	AQ
03/06	OssDsign AB announces updated proposal regarding board fees ahead of the annual general meeting 2026	AQ
06/05	OssDsign: Needs to prove slowdown is transitional – Q1 review	AQ
05/05	OssDsign: Full Q1 in line with profit warning	AQ
05/05	OssDsign AB (publ) publishes Q1 2026 interim report	AQ
28/04	OssDsign publishes Annual Report 2025	AQ
10/04	OssDsign: Preliminary Q1 figures reflect weak performance	AQ
10/04	OssDsign provides pre-release update on Q1 2026 performance	AQ
03/02	OssDsign: Sales slightly below but there are bright spots – Q4 initial	AQ
03/02	OssDsign AB (publ) publishes year-end report 2025	AQ
22/01	OssDsign: Sequential pick-up in organic momentum – Q4 preview	AQ
10/12	OssDsign: Mark Waugh appointed CEO	AQ
10/12	OssDsign appoints Mark Waugh as new CEO	AQ
04/11	OssDsign: A small bump on a long road – Q3 review	AQ
04/11	OssDsign Q3 25 - Interview	AQ
04/11	OssDsign AB (publ) publishes Q3 2025 interim report	AQ
15/10/25	OssDsign: Tough comparison but robust underlying – Q3 preview	AQ
20/08/25	OssDsign Q2 - Strong sales but higher costs ahead	AQ